Ameriprise Financial Inc Annexon, Inc. Transaction History
Ameriprise Financial Inc
- $356 Billion
- Q1 2025
A detailed history of Ameriprise Financial Inc transactions in Annexon, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 3,985,295 shares of ANNX stock, worth $9.76 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,985,295
Previous 926,642
330.08%
Holding current value
$9.76 Million
Previous $4.75 Million
61.81%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ANNX
# of Institutions
152Shares Held
96.8MCall Options Held
36.9KPut Options Held
83K-
Satter Management Co., L.P.7.41MShares$18.1 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$17.2 Million0.59% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$16.1 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$15.4 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.38MShares$13.2 Million0.0% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $117M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...